weight loss drug tirzepatide Wins FDA Approval for Lilly launches lower-price weight loss

It can, because Zepbound carries a separate indication for treating moderate to severe obstructive sleep apnea in adults with obesity, supported by its own trials, with recommended maintenance dosages of 10 mg or 15 mg once weekly for that indication

While these results in mice need to be replicated in people, and over a longer term, efforts to get those confirmations have already begun

The omega-class glutathione transferases: structure, function, and genetics

Clinical Evidence for GLP-1 Use in Menopause While most GLP-1 research has focused on people with type 2 diabetes or general weight management, emerging evidence suggests particular benefit for women navigating menopausal metabolic changes